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要　旨
　　ASPEN（American	Society	 for	Parenteral	and	Enteral	Nutrition）は 1976 年に米国で設立され、
臨床栄養・代謝の研究と実践を通して患者のケアを改善することを目指している1）。世界中に会員がお
り、2017 年現在 6,500 名以上で構成され、メンバーは医師、管理栄養士、薬剤師、看護師、研究者、学
生などである。会員は、栄養サポートに関する臨床実践、研究、教育の向上を追究している。
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1）共立女子大学　看護学部　2）山梨大学大学院　総合研究部
1．Introduction
	 Daily	 n-3	 polyunsaturated	 fatty	 acids	
（PUFAs）	intake	 is	 important	 for	patients	with	
inflammatory	bowel	disease2-3）.	 	In	 this	 study,	
we	 compared	 n-3	 PUFAs	 intake	 and	 serum	
fatty	acid	 levels	between	patients	with	Crohn’s	
disease	 and	 patients	with	 ulcerative	 colitis.	
Based	on	the	results,	we	provide	suggestions	for	





















Data Analysis:	 Student’s	 t-tests	were	used	 to	
evaluate	the	differences	in	nutritional	consump-
tion	 and	 serum	 lipid	 levels	between	 the	 two	
groups.
3．Results
	 In	 the	CD	group,	average	daily	 intakes	of	
PUFAs	（6.8±3.8	g）,	n-3	PUFAs	（1.1±0.5	g）,	
and	n-6	PUFAs	（5.5±3.5	g）	were	significantly	
lower	 than	 in	 the	UC	group	（p＜0.05）,	while	
the	n-6/n-3	intake	ratio	was	6.6±3.4	（6.4±2.3）	
in	 the	CD	group	（Table	2）.	 In	addition,	EPA	




Mean ± SD Mean ± SD
Total energy (kcal) 1898.9 ± 424.5 1987.3 ± 295.9 0.577
P:F:C ratio ‐
Total fat (g) 32.2 ± 20.9 59.9 ± 12.6 0.001
Cholesterol (mg) 275.5 ± 147.0 431.8 ± 94.2 0.008
SFA (g) 9.2 ± 6.7 16.9 ± 4.6 0.005
MUFA (g) 10.9 ± 7.9 21.1 ± 4.6 0.001
PUFA (g) 6.8 ± 3.8 12.4 ± 3.1 0.001
n-6 PUFAs (g) 5.5 ± 3.5 10.4 ± 2.7 0.001
n-6/n-3 ratio 6.6 ± 3.4 6.4 ± 2.3 0.908
Grains (g) 390.7 ± 150.2 453.2 ± 104.8 0.271
Vegetables (g) 178.7 ± 137.5 232.2 ± 109.3 0.325
Pulses (g) 18.4 ± 17.3 47.9 ± 44.4 0.054
Fish and shellﬁsh (g) 51.9 ± 50.0 58.4 ± 26.9 0.706
Meat (g) 55.3 ± 31.4 96.0 ± 33.0 0.008
Eggs (g) 36.7 ± 34.4 58.9 ± 13.6 0.060
Dairy Product (g) 41.7 ± 84.0 63.7 ± 47.7 0.459
Fats and Oils (g) 6.1 ± 5.4 12.6 ± 5.8 0.014
Food intake / day§2
§3 Six participants(54.5%) used elemental diet and the average daily energy intake was 950.0 ± 216.1 kcal.
§2 The date indicates the mean ± standard deviation of the ﬁve days dietary intakes.
§1 Student's t -test was used to calculate the statistical signiﬁcance(p＜0.05).
16.2 : 15.2 : 68.6 15.6 : 27.3 : 57.1
Nutrients / day§2
CD (n=11)§3 UC (n=11)
P value§1
Table 2. Nutrients and Food intake in Crohn’s disease patients
 ―Comparison with ulcerative colitis patients― 
N=22
Mean ± SD Mean ± SD
Age (y) 34.5 ± 11.6 40.3 ± 8.4 0.523
Duration of IBD (y) 9.2 ± 8.7 8.3 ± 8.1 0.531
BMI 22.0 ± 3.8 22.7 ± 5.1 0.498
Male n(%) 10 7(90.8) (63.6)
§1 Student's t -test was used to calculate the statistical signiﬁcance(p＜0.05).
CD (n=11) UC (n=11)
P value§1
















lower	than	that	 in	 the	UC	group.	 	The	n-6/n-3	
intake	 ratio	 and	 serum	n-6/n-3	 ratio	 in	 both	
groups	were	high.	 In	 the	CD	group	of	 the	n-3	
PUFAs,	EPA	and	DHA	intakes	were	particular-
ly	low.		Increasing	intake	of	EPA-	and	DHA-en-
Fig. 1　Intake of n-3 PUFAs, EPA, and DHA in Crohn’s disease patients
―Comparison with ulcerative colitis patients― :
＊ Student’s t-test was used to calculate the statistical significance（p ＜ 0.05）
Fig. 2　Serum n-3 PUFAs, EPA, and DHA in Crohn’s disease 
Patients ―Comparison with ulcerative colitis patients― :
＊ Student’s t-test was used to calculate the statistical significance （p ＜ 0.05）
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riched	 foods	（e.g.,	 fish）	would	be	able	 to	 im-
prove	 serum	n-3	PUFAs	 levels	 and	 alleviate	
inflammation4）.
Reference
 1）	ASPEN:	Leading	 the	Science	 and	Practice	 of	
Clinical	Nutritionⓒ	Copyright	 2017	American	
Society	 for	 Parenteral	 and	Enteral	Nutrition	
（ASPEN）
 2）	Shoda	R,	Matsueda	K,	Yamato	S	et	al.：Epidemi-
ologic	 analysis	 of	Crohn	disease	 in	 Japan	 in-
creased	dietary	intake	of	n-6	polyunsaturated	fat-
ty	 acids	 and	 animal	 protein	 relates	 to	 the	












Mean ± SD Mean ± SD
TG (mg/dL) 108.8 ± 31.2 102.9 ± 43.6 0.720
T-cho (mg/dL) 146.4 ± 33.7 181.2 ± 38.1 0.034
HDL-cho (g/dL) 45.2 ± 10.1 55.5 ± 13.2 0.540
LDL-cho (g/dL) 83.8 ± 29.0 106.5 ± 33.6 0.100
SFA (μg/mL) 922.5 ± 234.3 941.0 ± 206.9 0.840
MUFA (μg/mL) 701.0 ± 131.7 675.6 ± 202.2 0.730
PUFA (μg/mL) 1058.2 ± 273.0 1342.6 ± 292.1 0.290
n-6 PUFAs (μg/mL) 907.2 ± 271.6 1135.3 ± 257.0 0.570
n-6/n-3 ratio 6.5 ± 2.1 5.9 ± 1.3 0.460
CRP (mg/dL) 1.1 ± 1.0 0.6 ± 0.7 0.115




§1 Student's t -test was used to calculate the statistical signiﬁcance(p＜0.05).
Table 3　Serum lipid composition in Crohn’s disease patients
 ―Comparison with ulcerative colitis patients― 
